×
S&P 500   3,835.36 (+0.10%)
DOW   30,994.30 (+0.09%)
QQQ   286.80 (-0.06%)
AAPL   142.00 (+0.31%)
MSFT   263.93 (+0.41%)
META   166.45 (-1.03%)
GOOGL   2,247.44 (-0.79%)
AMZN   112.90 (-0.53%)
TSLA   686.99 (-1.75%)
NVDA   150.73 (+0.73%)
NIO   20.96 (-5.50%)
BABA   115.93 (-3.50%)
AMD   74.78 (-0.56%)
MU   57.86 (+1.99%)
CGC   2.64 (-2.58%)
T   21.12 (-0.24%)
GE   61.95 (-0.13%)
F   10.92 (-2.50%)
DIS   96.74 (-0.45%)
AMC   12.53 (-1.96%)
PFE   52.09 (+0.87%)
PYPL   74.00 (-0.54%)
NFLX   182.64 (-1.74%)
S&P 500   3,835.36 (+0.10%)
DOW   30,994.30 (+0.09%)
QQQ   286.80 (-0.06%)
AAPL   142.00 (+0.31%)
MSFT   263.93 (+0.41%)
META   166.45 (-1.03%)
GOOGL   2,247.44 (-0.79%)
AMZN   112.90 (-0.53%)
TSLA   686.99 (-1.75%)
NVDA   150.73 (+0.73%)
NIO   20.96 (-5.50%)
BABA   115.93 (-3.50%)
AMD   74.78 (-0.56%)
MU   57.86 (+1.99%)
CGC   2.64 (-2.58%)
T   21.12 (-0.24%)
GE   61.95 (-0.13%)
F   10.92 (-2.50%)
DIS   96.74 (-0.45%)
AMC   12.53 (-1.96%)
PFE   52.09 (+0.87%)
PYPL   74.00 (-0.54%)
NFLX   182.64 (-1.74%)
S&P 500   3,835.36 (+0.10%)
DOW   30,994.30 (+0.09%)
QQQ   286.80 (-0.06%)
AAPL   142.00 (+0.31%)
MSFT   263.93 (+0.41%)
META   166.45 (-1.03%)
GOOGL   2,247.44 (-0.79%)
AMZN   112.90 (-0.53%)
TSLA   686.99 (-1.75%)
NVDA   150.73 (+0.73%)
NIO   20.96 (-5.50%)
BABA   115.93 (-3.50%)
AMD   74.78 (-0.56%)
MU   57.86 (+1.99%)
CGC   2.64 (-2.58%)
T   21.12 (-0.24%)
GE   61.95 (-0.13%)
F   10.92 (-2.50%)
DIS   96.74 (-0.45%)
AMC   12.53 (-1.96%)
PFE   52.09 (+0.87%)
PYPL   74.00 (-0.54%)
NFLX   182.64 (-1.74%)
S&P 500   3,835.36 (+0.10%)
DOW   30,994.30 (+0.09%)
QQQ   286.80 (-0.06%)
AAPL   142.00 (+0.31%)
MSFT   263.93 (+0.41%)
META   166.45 (-1.03%)
GOOGL   2,247.44 (-0.79%)
AMZN   112.90 (-0.53%)
TSLA   686.99 (-1.75%)
NVDA   150.73 (+0.73%)
NIO   20.96 (-5.50%)
BABA   115.93 (-3.50%)
AMD   74.78 (-0.56%)
MU   57.86 (+1.99%)
CGC   2.64 (-2.58%)
T   21.12 (-0.24%)
GE   61.95 (-0.13%)
F   10.92 (-2.50%)
DIS   96.74 (-0.45%)
AMC   12.53 (-1.96%)
PFE   52.09 (+0.87%)
PYPL   74.00 (-0.54%)
NFLX   182.64 (-1.74%)
CVE:ZMD

ZoomMed Stock Forecast, Price & News

C$0.02
+0.02 (+∞)
(As of 10/4/2018)
Add
Compare
Today's Range
C$0.02
C$0.02
50-Day Range
C$0.02
C$0.02
52-Week Range
C$0.01
C$0.05
Volume
220,000 shs
Average Volume
290,486 shs
Market Capitalization
C$2.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ZoomMed MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.22 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive ZMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZoomMed and its competitors with MarketBeat's FREE daily newsletter.

About ZoomMed

ZoomMed Inc., together with its subsidiaries, develops and markets a range of computer applications designed for healthcare professionals primarily in the United States and the United Kingdom. The company builds and operates a clinical information exchange platform between physicians, pharmacists, and various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical companies, laboratories, physiotherapy clinics, and other organizations. It also offers ZRx Prescriber, a technological Web application that enables physicians to generate prescriptions. ZoomMed Inc. was incorporated in 2005 and is headquartered in Brossard, Canada.

ZMD Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$10,000.00
Book Value
C($0.02) per share

Miscellaneous

Free Float
N/A
Market Cap
C$2.03 million
Optionable
Not Optionable
Beta
N/A














ZoomMed Frequently Asked Questions

How has ZoomMed's stock performed in 2022?

ZoomMed's stock was trading at C$0.02 at the beginning of 2022. Since then, ZMD shares have increased by 0.0% and is now trading at C$0.02.
View the best growth stocks for 2022 here
.

Who are ZoomMed's key executives?

ZoomMed's management team includes the following people:
  • Mr. Yves Marmet, Chairman, CEO & Pres
  • Ms. Marie-Helene Pinard, CFO, VP of Operations & Fin., Sec. and Director
  • Mr. André Marmet, VP of Corp. Bus.

What is ZoomMed's stock symbol?

ZoomMed trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ZMD."

How do I buy shares of ZoomMed?

Shares of ZMD and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is ZoomMed's stock price today?

One share of ZMD stock can currently be purchased for approximately C$0.02.

How much money does ZoomMed make?

ZoomMed (CVE:ZMD) has a market capitalization of C$2.03 million and generates C$10,000.00 in revenue each year.

How can I contact ZoomMed?

ZoomMed's mailing address is 8005 du Quartier Blvd Suite 303, BROSSARD, QC J4Y 0N5, Canada. The official website for ZoomMed is zoommedcorpo.com. The company can be reached via phone at +1-450-6785457.

This page (CVE:ZMD) was last updated on 7/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.